文献速递药物不良反应与药物警戒

可预防的药物不良事件:描述性流行病学研究

Preventable adverse drug events: Descriptive epidemiology.
PubMed 文献 · Br J Clin Pharmacol · 2020-01-10

本研究回顾性分析三项前瞻性多中心观察性研究的急诊患者病历,由临床药师和医生独立评审药物不良事件的可预防性。精神健康诊断和糖尿病患者更易发生可预防事件,常见涉事药物包括华法林、氢氯噻嗪、呋塞米、胰岛素和阿司匹林。

要点

  • 64.1%的药物不良事件被认为可能或肯定可预防。
  • 精神健康诊断(OR 1.8)和糖尿病(OR 1.7)患者风险更高。
  • 华法林、氢氯噻嗪、呋塞米、胰岛素和阿司匹林是最常见涉事药物。

核心结论

  • 精神健康状况和糖尿病患者需要密切监测以预防药物不良事件。
  • 需要针对已识别的促成因素采取措施。

研究设计与样本

  • 回顾性病历审查,整合三项前瞻性多中心观察性研究的数据。
  • 临床药师和医生独立评审,第三评审员裁决分歧或不确定病例。

主要发现

  • 869起(64.1%)药物不良事件被认为可能或肯定可预防。
  • 精神健康诊断患者可预防事件的OR为1.8(95% CI 1.3-2.5)。
  • 糖尿病患者可预防事件的OR为1.7(95% CI 1.2-2.4)。
  • 可预防事件最常见涉事药物为华法林(9.4%)、氢氯噻嗪(4.5%)、呋塞米(4.0%)、胰岛素(3.9%)和阿司匹林(2.7%)。

关键数值与推荐

  • 可预防事件定义为评审者认为可能或肯定可预防。
  • 常见促成因素包括患者指导不足、监测和随访不足以及药物变更后未重新评估。

临床怎么用

  • 对精神健康诊断和糖尿病患者应加强用药监测和随访。
  • 关注华法林、利尿剂、胰岛素和阿司匹林等高风险药物的使用。
  • 改善患者用药指导,确保药物变更后及时重新评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Our objective was to identify preventable adverse drug events and factors contributing to their development. METHODS: We performed a retrospective chart review combining data from three prospective multicentre observational studies that assessed emergency department patients for adverse drug events. A clinical pharmacist and physician independently reviewed the charts, extracted data and rated the preventability of each adverse drug event. A third reviewer adjudicated all discordant or uncertain cases. We calculated the proportion of adverse drug events that were deemed preventable, performed multivariable logistic regression to explore the characteristics of patients with preventable events, and identified contributing factors. RESULTS: We reviewed the records of 1 356 adverse drug events in 1 234 patients. Raters considered 869 (64.1%) of adverse drug events probably or definitely preventable. Patients with mental health diagnoses (OR 1.8; 95% CI 1.3-2.5) and diabetes (OR 1.7; 95% CI 1.2-2.4) were more likely to present with preventable events. The medications most commonly implicated in preventable events were warfarin (9.4%), hydrochlorothiazide (4.5%), furosemide (4.0%), insulin (3.9%) and acetylsalicylic acid (2.7%). Common contributing factors included inadequate patient instructions, monitoring and follow-up, and reassessments after medication changes had been made. CONCLUSIONS: Our study suggests that patients with mental health conditions and diabetes require close monitoring. Efforts to address the identified contributing factors are needed.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Woo SA, Cragg A, Wickham ME, et al. Preventable adverse drug events: Descriptive epidemiology. Br J Clin Pharmacol. 2020. PMID: 31633827. doi:10.1111/bcp.14139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。